Literature DB >> 1582166

Pediatric blood culture evaluation of the BACTEC PEDS Plus and the DuPont Isolator 1.5 systems.

K Eisenach1, J Dyke, M Boehme, B Johnson, M B Cook.   

Abstract

A new nonradiometric BACTEC medium has been developed for culturing pediatric blood samples. The BACTEC PEDS Plus medium (BACTEC PED) consists of 20 ml of an enriched broth with resins. In contrast to the other aerobic BACTEC media, there is a lower concentration of sodium polyanetholesulfonate in the medium and more CO2 in the headspace of the vial. This study was conducted in two different pediatric settings to compare the performance of the BACTEC PED medium with the Du Pont Isolator 1.5 system (ISO 1.5) in terms of overall organism recovery and time to detection. Equal volumes of up to 1.5 ml were tested in both systems. A total of 4063 culture sets were analyzed, yielding 301 (7.4%) clinically significant isolates. Of these, 86 (29%) were recovered only from the BACTEC PED and 12 (4%) only from the ISO 1.5 (p less than 0.001). BACTEC PED recovered significantly more staphylococci and Enterobacteriaceae than ISO 1.5 (p less than 0.001 and p less than 0.005, respectively). Detection times of isolates recovered in both systems were comparable. For those patients on antibiotic therapy at the time of culture, 21 (37%) were positive only in the BACTEC PED, whereas two (4%) were positive only in the ISO 1.5. The nontherapy group had 61 (27%) organisms that were detected in BACTEC PED only and 9 (4%) in ISO 1.5 only. These results indicate that BACTEC PED is a significant advance in blood culture systems that will provide a sensitive method for detecting pediatric bacteremias.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582166     DOI: 10.1016/0732-8893(92)90117-c

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  7 in total

1.  Evaluation of manufacturer's recommended growth value thresholds for BACTEC media.

Authors:  A G Matlow; S Camack; B Taylor; B Burkholder
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

2.  Blood Volume Required for Detection of Low Levels and Ultralow Levels of Organisms Responsible for Neonatal Bacteremia by Use of Bactec Peds Plus/F, Plus Aerobic/F Medium, and the BD Bactec FX System: an In Vitro Study.

Authors:  Diana P Lancaster; David F Friedman; Kathleen Chiotos; Kaede V Sullivan
Journal:  J Clin Microbiol       Date:  2015-08-19       Impact factor: 5.948

3.  Controlled comparison of bioMérieux VITAL and BACTEC NR-660 systems for detection of bacteremia and fungemia in pediatric patients.

Authors:  A K Zaidi; S Mirrett; J C McDonald; E E Rubin; L C McDonald; M P Weinstein; M Gupta; L B Reller
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

4.  Comparison of BACTEC MYCO/F LYTIC and WAMPOLE ISOLATOR 10 (lysis-centrifugation) systems for detection of bacteremia, mycobacteremia, and fungemia in a developing country.

Authors:  L K Archibald; L C McDonald; R M Addison; C McKnight; T Byrne; H Dobbie; O Nwanyanwu; P Kazembe; L B Reller; W R Jarvis
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

5.  Pneumolysin PCR-based diagnosis of invasive pneumococcal infection in children.

Authors:  P Toikka; S Nikkari; O Ruuskanen; M Leinonen; J Mertsola
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

6.  Comparison of Isolator 1.5 and BACTEC NR660 aerobic 6A blood culture systems for detection of fungemia in children.

Authors:  C A Petti; A K Zaidi; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

7.  Systemic bacteraemia in children presenting with clinical pneumonia and the impact of non-typhoid salmonella (NTS).

Authors:  Norbert G Schwarz; Nimako Sarpong; Frank Hünger; Florian Marks; Samuel Ek Acquah; Alex Agyekum; Bernard Nkrumah; Wibke Loag; Ralf M Hagen; Jennifer A Evans; Denise Dekker; Julius N Fobil; Christian G Meyer; Jürgen May; Yaw Adu-Sarkodie
Journal:  BMC Infect Dis       Date:  2010-11-04       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.